Ignite Creation Date:
2025-12-24 @ 4:14 PM
Ignite Modification Date:
2026-01-26 @ 1:08 AM
Study NCT ID:
NCT04077866
Status:
UNKNOWN
Last Update Posted:
2022-12-28
First Post:
2019-08-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
B7-H3 CAR-T for Recurrent or Refractory Glioblastoma
Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
SAHZJU-RCT-BP102
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None